{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:21:48Z","timestamp":1790144508791,"version":"4.0.1"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010296","name":"James B. Pendleton Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010296","id-type":"DOI","asserted-by":"publisher"}]},{"name":"San Diego Center for AIDS Research","award":["P30 AI03621"],"award-info":[{"award-number":["P30 AI03621"]}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA1049644"],"award-info":[{"award-number":["R01 DA1049644"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01 DA049665"],"award-info":[{"award-number":["K01 DA049665"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R03 DA57142"],"award-info":[{"award-number":["R03 DA57142"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21 AI67889"],"award-info":[{"award-number":["R21 AI67889"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA023356"],"award-info":[{"award-number":["DA023356"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Few estimates exist of the prevalence of sexually transmitted infections (STIs) and associated risk factors among people who inject drugs (PWID) in the San Diego\u2013Tijuana border region, despite the high prevalence of HIV.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>PWID living in San Diego or Tijuana underwent testing for bacterial STIs between December 2022 and February 2024. Urogenital gonorrhea and chlamydia infections were assessed using a urine test, the Aptima CT\/GC assay. Syphilis was assessed using the treponemal Syphilis Health Check Rapid Point-of-Care assay and nontreponemal rapid plasma reagin Treponema pallidum Particle Agglutination test. HIV was tested using the fingerstick tests Miriad HCV\/HIV POU+ Test and Oraquick HIV-1. Bacterial STI prevalence was calculated, and logistic regression was conducted to identify correlates of bacterial STI prevalence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 519 participants, 6.0% (95% CI, 3.9%\u20138.0%) tested positive for 1 or more bacterial STIs. Despite higher HIV prevalence in Tijuana, bacterial STIs were more prevalent in San Diego. Unstable housing, female birth, and US residency were associated with significantly higher adjusted odds of a bacterial STI compared with the reference groups (aOR, 2.61; 95% CI, 1.09\u20136.27; aOR, 2.41; 95% CI, 1.15\u20135.08; and OR, 2.79; 95% CI, 1.03\u20137.53; respectively).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Overall prevalence of bacterial STIs was consistent with other estimates of STIs among PWID in the United States. STI screening guidelines should recommend PWID for routine testing at least annually. Point-of-care testing should be expanded to increase access to STI screening and treatment for marginalized populations.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf171","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T04:35:51Z","timestamp":1742704551000},"source":"Crossref","is-referenced-by-count":3,"title":["Prevalence and Factors Associated With Sexually Transmitted Infections Among People who Inject Drugs in the San Diego\u2013Tijuana Border Region"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2533-3034","authenticated-orcid":false,"given":"Carrie L","family":"Nacht","sequence":"first","affiliation":[{"name":"Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego , San Diego, California ,","place":["USA"]},{"name":"School of Public Health, San Diego State University , San Diego, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7724-691X","authenticated-orcid":false,"given":"Steffanie A","family":"Strathdee","sequence":"additional","affiliation":[{"name":"Division of Infections Disease and Global Public Health, University of California San Diego , San Diego, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8708-8169","authenticated-orcid":false,"given":"Alicia","family":"Harvey-Vera","sequence":"additional","affiliation":[{"name":"Division of Infections Disease and Global Public Health, University of California San Diego , San Diego, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos F","family":"Vera","sequence":"additional","affiliation":[{"name":"Division of Infections Disease and Global Public Health, University of California San Diego , San Diego, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudelia","family":"Rangel","sequence":"additional","affiliation":[{"name":"Departamento de Estudios de Poblacion, El Colegio de la Frontera Norte , Tijuana, Baja California ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D","family":"Klausner","sequence":"additional","affiliation":[{"name":"Department of Population and Public Health Sciences, University of Southern California , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Artamonova","sequence":"additional","affiliation":[{"name":"Division of Infections Disease and Global Public Health, University of California San Diego , San Diego, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2969-7193","authenticated-orcid":false,"given":"Daniela","family":"Abramovitz","sequence":"additional","affiliation":[{"name":"Division of Infections Disease and Global Public Health, University of California San Diego , San Diego, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8780-3612","authenticated-orcid":false,"given":"Britt","family":"Skaathun","sequence":"additional","affiliation":[{"name":"Division of Infections Disease and Global Public Health, University of California San Diego , San Diego, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"2025052712081672000_ofaf171-B1","doi-asserted-by":"crossref","first-page":"105779","DOI":"10.1016\/j.ypmed.2019.105779","article-title":"Sexual risk behaviors and STDs among persons who inject drugs: a national study","volume":"126","author":"Brookmeyer","year":"2019","journal-title":"Prev Med"},{"key":"2025052712081672000_ofaf171-B2","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1177\/0956462420950603","article-title":"Illicit drug use and sexually transmitted infections among young adults in the US: evidence from a nationally representative survey","volume":"31","author":"Haider","year":"2020","journal-title":"Int J STD AIDS"},{"key":"2025052712081672000_ofaf171-B3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/COH.0000000000000041","article-title":"Estimating the size of key populations: current status and future possibilities","volume":"9","author":"Abdul-Quader","year":"2014","journal-title":"Curr Opin HIV AIDS"},{"key":"2025052712081672000_ofaf171-B4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.addbeh.2010.08.027","article-title":"Non-medical use of prescription drugs and sexual risk behavior in young adults","volume":"36","author":"Benotsch","year":"2011","journal-title":"Addict Behav"},{"key":"2025052712081672000_ofaf171-B5","author":"US General Services Administration"},{"key":"2025052712081672000_ofaf171-B6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/02791072.2005.10400528","article-title":"HIV prevalence and correlates of receptive needle sharing among injection drug users in the Mexican-U.S. border city of Tijuana","volume":"37","author":"Magis-Rodr\u00edguez","year":"2005","journal-title":"J Psychoactive Drugs"},{"key":"2025052712081672000_ofaf171-B7","author":"City of San Diego"},{"key":"2025052712081672000_ofaf171-B8","author":"Morales"},{"key":"2025052712081672000_ofaf171-B9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10900-018-0562-5","article-title":"Social determinants of sexual behavior and awareness of sexually transmitted infections (STI) among low-income HIV+ or STI at-risk hispanic residents receiving care at the U.S.\u2013Mexico border","volume":"44","author":"Tabler","year":"2019","journal-title":"J Community Health"},{"key":"2025052712081672000_ofaf171-B10","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.2105\/AJPH.2007.130096","article-title":"Efficacy of a brief behavioral intervention to promote condom use among female sex workers in Tijuana and Ciudad Juarez, Mexico","volume":"98","author":"Patterson","year":"2008","journal-title":"Am J Public Health"},{"key":"2025052712081672000_ofaf171-B11","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1007\/s10903-019-00868-8","article-title":"Prevalence and correlates of injecting with visitors from the United States among people who inject drugs in Tijuana, Mexico","volume":"21","author":"B\u00f3rquez","year":"2019","journal-title":"J Immigr Minor Health"},{"key":"2025052712081672000_ofaf171-B12","author":"County of San Diego Health and Human Services Agency, Division of Public Health Services, HIV, STD, and Hepatitis Branch"},{"key":"2025052712081672000_ofaf171-B13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/OLQ.0b013e3181deaa0f","article-title":"Distribution of sexually transmitted diseases and risk factors by work locations among female sex workers in Tijuana, Mexico","volume":"37","author":"Rusch","year":"2010","journal-title":"Sex Transm Dis"},{"key":"2025052712081672000_ofaf171-B14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugalcdep.2007.07.001","article-title":"Correlates of injection drug use among female sex workers in two Mexico-U.S. border cities","volume":"92","author":"Strathdee","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"2025052712081672000_ofaf171-B15","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/0956462420987757","article-title":"Prevalence of bacterial sexually transmitted infections and coinfection with HIV among men who have sex with men and transgender women in Tijuana, Mexico","volume":"32","author":"Bristow","year":"2021","journal-title":"Int J STD AIDS"},{"key":"2025052712081672000_ofaf171-B16","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1177\/0956462414568394","article-title":"Incident syphilis infection among people who inject drugs in Tijuana, Mexico","volume":"26","author":"Pines","year":"2015","journal-title":"Int J STD AIDS"},{"key":"2025052712081672000_ofaf171-B17","author":"US Census Bureau"},{"key":"2025052712081672000_ofaf171-B18","author":"Tijuana Municipality of Baja California","year":"2020"},{"key":"2025052712081672000_ofaf171-B19","doi-asserted-by":"crossref","first-page":"e0260286","DOI":"10.1371\/journal.pone.0260286","article-title":"Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego-Tijuana border region","volume":"16","author":"Strathdee","year":"2021","journal-title":"PLoS One"},{"key":"2025052712081672000_ofaf171-B20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13722-022-00328-z","article-title":"Study protocol for a pilot randomized controlled trial to increase COVID-19 testing and vaccination among people who inject drugs in San Diego County","volume":"17","author":"Bazzi","year":"2022","journal-title":"Addict Sci Clin Pract"},{"key":"2025052712081672000_ofaf171-B21","author":"Aptima Combo 2 package insert AW-19693-001","year":"2020"},{"key":"2025052712081672000_ofaf171-B22","author":"Everly Health"},{"key":"2025052712081672000_ofaf171-B23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1309\/AJCPFQ25SQVZAWHZ","article-title":"Evaluation of the Hologic Gen-Probe PANTHER, APTIMA Combo 2 assay in a tertiary care teaching hospital","volume":"141","author":"Cheng","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"2025052712081672000_ofaf171-B24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12879-018-3629-0","article-title":"Comparison of an in-house real-time duplex PCR assay with commercial HOLOGIC\u00ae APTIMA assays for the detection of Neisseria gonorrhoeae and Chlamydia trachomatis in urine and extra-genital specimens","volume":"19","author":"Venter","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2025052712081672000_ofaf171-B25","volume-title":"Syphilis Health Check\u2122 rapid point-of-care syphilis testing","author":"Diagnostics Direct"},{"key":"2025052712081672000_ofaf171-B26","author":"Labcorp"},{"key":"2025052712081672000_ofaf171-B27","doi-asserted-by":"crossref","first-page":"ofv101","DOI":"10.1093\/ofid\/ofv101","article-title":"Comparison of rapid point-of-care tests for detection of antibodies to hepatitis C virus","volume":"2","author":"Fisher","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"2025052712081672000_ofaf171-B28","author":"Orasure"},{"key":"2025052712081672000_ofaf171-B29","author":"US Food and Drug Administration"},{"key":"2025052712081672000_ofaf171-B30","doi-asserted-by":"crossref","DOI":"10.2471\/B09080","volume-title":"Consolidated Guidelines on Differentiated HIV Testing Services","author":"World Health Organization","year":"2024"},{"key":"2025052712081672000_ofaf171-B31","author":"Reuters"},{"key":"2025052712081672000_ofaf171-B32","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1177\/0956462414555930","article-title":"Predictors identifying those at increased risk for STDs: a theory-guided review of empirical literature and clinical guidelines","volume":"26","author":"Falasinnu","year":"2015","journal-title":"Int J STD AIDS"},{"key":"2025052712081672000_ofaf171-B33","author":"Centers for Disease Control and Prevention"},{"key":"2025052712081672000_ofaf171-B34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10903-007-9073-7","article-title":"Barriers to HIV care in the context of cross-border health care utilization among HIV-positive persons living in the California\/Baja California US-Mexico border region","volume":"10","author":"Z\u00fa\u00f1iga","year":"2008","journal-title":"J Immigr Minor Health"},{"key":"2025052712081672000_ofaf171-B35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugpo.2016.12.010","article-title":"Differential experiences of Mexican policing by people who inject drugs residing in Tijuana and San Diego","volume":"41","author":"Wood","year":"2017","journal-title":"Int J Drug Policy"},{"key":"2025052712081672000_ofaf171-B36","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/COH.0b013e3283536ab2","article-title":"Dual HIV risk and vulnerabilities among women who use or inject drugs: no single prevention strategy is the answer","volume":"7","author":"El-Bassel","year":"2012","journal-title":"Curr Opin HIV AIDS"},{"key":"2025052712081672000_ofaf171-B37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2017.01.097","article-title":"Stigma and social support in substance abuse: implications for mental health and well-being","volume":"252","author":"Birtel","year":"2017","journal-title":"Psychiatry Res"},{"key":"2025052712081672000_ofaf171-B38","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.drugalcdep.2018.06.009","article-title":"Frequent experience of discrimination among people who inject drugs: links with health and wellbeing","volume":"190","author":"Couto e Cruz","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"2025052712081672000_ofaf171-B39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.drugalcdep.2017.10.009","article-title":"Do law enforcement interactions reduce the initiation of injection drug use? An investigation in three North American settings","volume":"182","author":"Melo","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"2025052712081672000_ofaf171-B40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.drugalcdep.2015.01.011","article-title":"Police bribery and access to methadone maintenance therapy within the context of drug policy reform in Tijuana, Mexico","volume":"148","author":"Werb","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"2025052712081672000_ofaf171-B41","author":"County of San Diego Health and Human Services Agency Public Health Services HIV STD, and Hepatitis Branch"},{"key":"2025052712081672000_ofaf171-B42","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/ADM.0000000000000327","article-title":"Pilot studies examining feasibility of substance use disorder screening and treatment linkage at urban sexually transmitted disease clinics","volume":"11","author":"Gryczynski","year":"2017","journal-title":"J Addict Med"},{"key":"2025052712081672000_ofaf171-B43","author":"Centers for Disease Control and Prevention"},{"key":"2025052712081672000_ofaf171-B44","author":"Centers for Disease Control and Prevention"},{"key":"2025052712081672000_ofaf171-B45","author":"US Preventive Services Task Force"},{"key":"2025052712081672000_ofaf171-B46","author":"California Department of Public Health"},{"key":"2025052712081672000_ofaf171-B47","author":"Palacios","year":"2011"},{"key":"2025052712081672000_ofaf171-B48","author":"Centers for Disease Control and Prevention"},{"issue":"S4","key":"2025052712081672000_ofaf171-B49","first-page":"S3","article-title":"A systematic review and meta-analysis of studies evaluating the performance and operational characteristics of dual point-of-care tests for HIV and syphilis","volume":"93","author":"Gliddon","year":"2017","journal-title":"Sex Transm Infect"},{"issue":"8S","key":"2025052712081672000_ofaf171-B50","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1097\/OLQ.0000000000001457","article-title":"A narrative review of where we are with point-of-care sexually transmitted infection testing in the United States","volume":"48","author":"Gaydos","year":"2021","journal-title":"Sex Transm Dis"},{"key":"2025052712081672000_ofaf171-B51","article-title":"FDA grants marketing authorization of first test for chlamydia and gonorrhea with at-home sample collection","author":"US Food and Drug Administrtion"},{"key":"2025052712081672000_ofaf171-B52","author":"United Nations Office on Drugs and Crime"},{"key":"2025052712081672000_ofaf171-B53","first-page":"100751","article-title":"HIV-1 transmission dynamics among people who inject drugs on the US\/Mexico border during the COVID-19 pandemic: a prosepective cohort study","volume":"33","author":"Skaathun","year":"2024","journal-title":"Lancet Reg Health Am"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf171\/62500140\/ofaf171.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/4\/ofaf171\/62500140\/ofaf171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/4\/ofaf171\/62500140\/ofaf171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:08:45Z","timestamp":1748362125000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf171\/8089779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf171","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,3,21]]},"article-number":"ofaf171"}}